跳至主要内容
临床试验/CTRI/2018/08/015228
CTRI/2018/08/015228已完成3 期

Effects of homoeopathic intervention in stage I essential hypertensive patients: a randomized double blind, placebo controlled trial.

Central Council for Research in Homoeopathy0 个研究点目标入组 214 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
214

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. 30 to 60 yrs
  • 2.Both genders
  • 3.Essential hypertension of stage I (SBP 140-159; DBP 90-99)
  • 4.Patients who were not on any anti-hypertensive medicine since last 1 month.
  • 5.Patients willing to participate in the study.

排除标准

  • 1.Patients with secondary hypertension of any etiology.
  • 2.Patients with pre hypertension, stage II hypertension as per JNC 7 criteria.
  • 3.Known Diabetics.
  • 4.Patients with a history of myocardial infarction, severe coronary artery disease or clinically significant heart failure or valvular defect or known cases of cardiac diseases.
  • 5.Patients with systemic illness
  • 6.Patients receiving any drugs known to affect blood pressure
  • 7.Patients judged to have a history of alcohol or drug abuse
  • 8.Women who are taking contraceptive pills, pregnancy and lactating mother.
  • 9.Patients suffering from hypothyroidism.
  • 10.Unable or unwilling to give informed consent

研究者

发起方
Central Council for Research in Homoeopathy

相似试验

A clinical trial to study effect of Homoeopathy and... | 临床试验